Cdk Inhibitors
CDK Inhibitors is a class of regulatory proteins that function as negative regulators of the cell cycle by specifically binding to and inhibiting cyclin-dependent kinase complexes, thereby preventing aberrant cell proliferation.
3.1K
Publications
251.8K
Citations
19.2K
Authors
2.9K
Institutions
Publications per year
2017–2026
904
Parents
3.1K
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Tsutomu Nobori, Kaoru Miura, David Wu et al. · Nature · 1994 · 1.8K citations
1–5 of 3.1K
19.2K
43
h-index
31
h-index
20
h-index
19
h-index
18
h-index
1–5 of 19.2K
2.9K
Harvard University
Cambridge, United States
69 h-index
120 publications
18.4K citations

Howard Hughes Medical Institute
Chevy Chase, United States
61 h-index
77 publications
24.6K citations
Dana-Farber Cancer Institute
Boston, United States
60 h-index
107 publications
15.1K citations

Centre National de la Recherche Scientifique
Paris, France
48 h-index
91 publications
9.9K citations
Memorial Sloan Kettering Cancer Center
New York, United States
40 h-index
59 publications
15.4K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
39 h-index
80 publications
4.8K citations

Cornell University
Ithaca, United States
34 h-index
49 publications
5.6K citations
Massachusetts General Hospital
Boston, United States
32 h-index
44 publications
7.2K citations
1–8 of 2.9K
JBC · 123 publications · 11.8K citations
64
h-index
MCB · 74 publications · 10.8K citations
56
h-index
92 publications · 8.1K citations
56
h-index
Repository · 138 publications · 10.2K citations
55
h-index
PNAS · 56 publications · 10.1K citations
48
h-index
1–5